Chronic Lymphocytic Leukaemia Presenting with Pancytopenia: A Rare Haematological Coincidence

被引:0
|
作者
Jamal, Iffat [1 ]
Smita, Shuchi [1 ]
Raman, Ravi Bhushan [1 ]
Kumar, Kaushal [1 ]
Choudhary, Vijayanand [1 ]
机构
[1] Indira Gandhi Inst Med Sci, Dept Hematol Pathol, Patna, Bihar, India
关键词
Autoimmune; Cytopenias; Evans syndrome; Lymphocyte count; AUTOIMMUNE HEMOLYTIC-ANEMIA; FLUDARABINE; RITUXIMAB; CYCLOPHOSPHAMIDE; EXPRESSION; SURVIVAL;
D O I
10.7860/JCDR/2021/46541.14858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic Lymphocytic Leukaemia ( CLL) is commonly associated with autoimmune cytopenias but CLL presenting with pancytopenia is a rare occurrence. Here, we present a case of 56-year- old male patient, who presented with pallor, mild hepatosplenomegaly, right-sided pleural effusion in chest x-ray, pancytopenia and his bone marrow showed infiltration by mature appearing lymphoid cells making a diagnosis of CLL. Despite the frequency of these immune mediated cytopenia, only few cases of pancytopenia have been described so far to the best of our knowledge. Hence, to emphasise the rarity of such haematological coincidence we are presenting this case report. CLL generally presents with persistent absolute lymphocytosis on peripheral smear with an absolute monoclonal lymphocyte count of more than 5000/cumm. There is a common association with Autoimmune Haemolytic Anaemia (AIHA) and Immune Thrombocytopenia (ITP) and the association is called as Evan's syndrome. Its pathogenesis is associated with autoimmune process. AIHA, ITP, and Pure Red Cell Aplasia (PRCA) are commonly associated complications seen in CLL. The pathogenesis of AIHA and ITP are antibody this inplace of the reactions and abnormal T cell activity is noted in the pathogenesis of PRCA. Despite of the frequency of these immune mediated cytopenias noted in CLL, bone marrow was seen to be hypercellular in most of the cases and marrow hypoplasia have been reported in only 2 cases reported in literature so far. In the present case, although pancytopenia was present on peripheral blood smear examination but bone marrow was hypercellular for age with diffuse infiltration by monoclonal mature appearing lymphoid cells which makes this case all the more interesting. Despite repeated blood transfusions,antiviral drug Tenofovir and aggressive supportive measures for 6 months, he developed right-sided pleural effusion and succumbed to his illness.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Is chemoimmunotherapy maintenance of value in patients with chronic lymphocytic leukaemia and minimal residual disease?
    Fink, Anna M.
    LANCET HAEMATOLOGY, 2019, 6 (09): : E441 - E442
  • [32] Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
    Al-Sawaf, Othman
    Bahlo, Jasmin
    Robrecht, Sandra
    Fischer, Kirsten
    Herling, Carmen D.
    Hoechstetter, Manuela
    Fink, Anna-Maria
    von Tresckow, Julia
    Langerbeins, Petra
    Cramer, Paula
    Stilgenbauer, Stephan
    Wendtner, Clemens M.
    Eichhorst, Barbara
    Hallek, Michael
    Goede, Valentin
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (05) : 727 - 735
  • [33] The Genomic Landscape of Chronic Lymphocytic Leukaemia: Clinical Implications
    Ridout, Kate
    Robbe, Pauline
    Vavoulis, Dimitris
    Klintman, Jenny
    Stamatopoulos, Basile
    Bruce, David
    Burns, Adam
    Cavalieri, Doriane
    Dreau, Helene
    Schuh, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S112 - S115
  • [34] Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
    Milne, Kate
    Sturrock, Beattie
    Chevassut, Timothy
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [35] First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    ANNALS OF HEMATOLOGY, 2015, 94 (06) : 1003 - 1009
  • [36] Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia
    Shanafelt, Tait D.
    Byrd, John C.
    LaPlant, Betsy
    Zent, Clive S.
    Call, Tim
    Secreto, Charla
    Grever, Michael R.
    Lin, Thomas S.
    Kay, Neil E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (06) : 660 - 664
  • [37] Advances in the treatment of chronic lymphocytic leukaemia
    Mozas, Pablo
    Delgado, Julio
    MEDICINA CLINICA, 2016, 147 (10): : 447 - 454
  • [38] Genetic alterations in chronic lymphocytic leukaemia
    Coll-Mulet, Llorenc
    Gil, Joan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (04) : 194 - 198
  • [39] Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
    Freeman, Ciara L.
    Gribben, John G.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (01) : 29 - 36
  • [40] An overview of chronic lymphocytic leukaemia biology
    Bertilaccio, M. T. S.
    Scielzo, C.
    Muzio, M.
    Caligaris-Cappio, F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (01) : 21 - 32